Thus, MED15 knockdown has been linked to reduced growth and decreased transcriptional activation, while MED15 is highly overexpressed in different human cancers, including head and neck squamous cell carcinomas, hepatocellular carcinoma, breast cancer, renal cell carcinoma, and testicular germ cell tumours. This evidence concerns the gene MED15 and renal cell carcinoma.